Drug Profile
Clentiazem
Alternative Names: Clentiazem maleate; Logna®; TA 3090Latest Information Update: 16 Oct 2001
Price :
$50
*
At a glance
- Originator Tanabe Seiyaku
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Atherosclerosis; Hypertension; Reperfusion injury; Stroke; Supraventricular tachycardia
Most Recent Events
- 16 Oct 2001 No-Development-Reported for Angina pectoris in Canada (Unknown route)
- 16 Oct 2001 No-Development-Reported for Angina pectoris in France (Unknown route)
- 16 Oct 2001 No-Development-Reported for Angina pectoris in Germany (Unknown route)